CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Financial highlights
| Metric | FY 12/27/25 | FY 12/28/24 | FY 12/30/23 | FY 12/31/22 | FY 12/25/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.0 | $4.0 | $4.1 | $4.0 | $3.5 |
| Operating income | $<0.1 | $0.2 | $0.6 | $0.7 | $0.6 |
| Net income | -$0.1 | $<0.1 | $0.5 | $0.5 | $0.4 |
| Balance Sheet | |||||
| Total debt | $2.1 | $2.2 | $2.6 | $2.7 | $2.7 |
| Cash Flow Statement | |||||
| Free cash flow | $0.5 | $0.5 | $0.4 | $0.3 | $0.5 |
| Share repurchases | $0.4 | $0.1 | $<0.1 | $<0.1 | $<0.1 |
Shares outstanding 47.7M · Free float 92.8%
Annual filing data through FY ended December 27, 2025; float as of September 25, 2026.